US Congress drafts funding boost

Biomedical advocates worry about NIH shortfall as Fiscal 2008 budget process begins in Congress

Written byTed Agres
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Spending bills for Fiscal 2008 drafted thus far in the U.S. House of Representatives would provide "significant increases" for key federal agency research and development programs for the first time in four years, a new analysis states. But the proposals sharply exceed budget requests by the administration of President George W. Bush, and therefore risk being vetoed. The House's proposed increase for the National Institutes of Health - while significantly larger than the White House has requested - will once again be insufficient for the NIH to keep pace with the rate of biomedical inflation, estimated at 3.7% for the fiscal year starting Oct. 1, 2007. "It's clear that the House is interested in increasing R&D funding relative to scientific innovation, climate change, and renewable energy," said Kei Koizumi, director of the R&D Budget and Policy Program at the American Association for the Advancement of Science (AAAS). "Of course the NIH budget is really big, so it takes many more dollars to increase NIH in any significant way," he told The Scientist. According to AAAS's budget analysis released last week (June 14), appropriations bills crafted in the House would boost funding for all major R&D funding agencies, including the Departments of Energy, Interior, and the Environmental Protection Agency. On June 11, a House Appropriations subcommittee approved $6.5 billion for the National Science Foundation, a 10% increase of $593 million over Fiscal 2007, and $80 million more than the president's budget request. Bush has threatened to veto any individual spending bill that exceeds his original request. Ten of the 12 spending bills, including that for NIH, could fall into that category, Koizumi said. On June 7 the House Appropriations Subcommittee on Labor-HHS-Education approved its spending bill, which proposes giving NIH $29.7 billion, an increase of $750 million (2.6%) above the current year, and $1 billion (3.6%) more than the president's request. This would increase the number of new and competing research grants by approximately 545 over last year, and help slightly increase the average cost of new research grants. "There's not a lot of programs on the discretionary spending side that got a $1 billion increase," said Dave Moore, senior associate vice president at the Association of American Medical Colleges (AAMC). "A lot of people are disappointed, but there just wasn't enough money to go around," he told The Scientist.Because the House bill also increases the amount transferred from NIH to the Global HIV/AIDS fund from $99 million in Fiscal 2007 to $300 million in Fiscal 2008, the net increase to the NIH budget is only $549 million (1.9%). "That means NIH will lose close to half of the expected inflationary rate increase for 2008," Jon Retzlaff, legislative affairs director for the Federation of American Societies for Experimental Biology (FASEB), told The Scientist.The Senate Labor-HHS-Education Appropriations Subcommittee is scheduled to begin work on its bill tomorrow (June 19). But the subcommittee will be starting with a $149.2 billion allocation for all the departments under its jurisdiction, an increase of $4.7 billion (3.3%) over Fiscal 2007 but $1.9 billion less than the amount the House subcommittee started with. "Obviously, we've got a long way to go in the Senate," Moore said. The House Labor-HHS-Education funding bill still needs approval by the full Appropriations Committee (expected in early July) and then by all House members. Differences must be reconciled with the Senate version before it can be sent to the president. Ted Agres mail@the-scientist.comLinks within this article Biomedical Research and Development Price Index: FY 2006 Update and Projections for FY 2007-2012, Feb. 5, 2007 http://www.the-scientist.com/news/home/49077/"R&D in the FY 2008 Budget," American Association for the Advancement of Science (AAAS), June 14, 2007 http://www.aaas.org/spp/rd/fy08.htmHouse of Representatives Fiscal 2008 Labor-HHS-Education spending bill http://appropriations.house.gov/pdf/08LHDetail_HouseSC_WEB.pdfT. Agres, "Flat NIH funding again in '08," The Scientist, Feb. 6, 2007 http://www.the-scientist.com/news/home/49077/Global Fund to Fight HIV/AIDS, Tuberculosis, and Malaria http://www.theglobalfund.org/en
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies